Lam Research Likely to Benefit from Healthy Wafer Fabrication Equipment Landscape, RBC Says

-- Lam Research (LRCX) is likely to benefit from healthy wafer fabrication equipment environment for the next two to three years driven by generative AI demand and memory tightness, RBC Capital Markets said in a Wednesday research report.

The brokerage said it raised its fiscal 2026 and 2027 EPS guidance to $5.65 and $7.72, respectively, from $5.30 and $6.84 earlier.

The company's fiscal Q3 beat was particularly driven by strength in DRAM and improving NAND outlook amid continued momentum in high bandwidth memory, analysts wrote.

China exposure declined during the quarter, and the company expects further declines as global spending accelerates, but overall, China demand remains steady, according to the note.

RBC reiterated its outperform rating on the stock and boosted its price target to $310 from $290.

Price: $261.88, Change: $-3.68, Percent Change: -1.38%

Newmont Posts Higher Q1 Adjusted Earnings, Sales

Newmont (ASX:NEM) reported Friday first-quarter adjusted earnings of $2.90 per share, up from $1.25 a year earlier.Analysts polled by FactSet expected earnings of $2.18.Sales for the three months ended March 31, was $7.31 billion, compared with $5.01 billion a year earlier. Analysts surveyed by FactSet expected $6.57 billion.The board declared a quarterly dividend of $0.26 per share, up from $0.25 a year earlier, payable June 22 to shareholders on record as of May 27.

$ASX:NEM

Research Alert: Pfg Q1 Eps Beat On Strong Retirement/benefits; Buybacks Key To 9%-12% Goal

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PFG posted Q1 operating EPS of $2.07 versus $1.81 a year ago, missing our $2.24 estimate but topping the $2.01 consensus view on solid Y/Y performance. Operating EPS excluding significant variances of $2.17 versus $1.92 reflected meaningful improvement across several business segments. We applaud these results but caution Q1 may not represent a sustainable run rate given the volatile and transactional nature of many areas within the core Retirement and Income Solutions unit, though we view positively the margin gains achieved in Specialty Benefits. Management reiterated its earlier guidance for 9% to 12% operating EPS growth in 2026. We note Life Insurance results remain somewhat pressured while Investment Management continues to be plagued by net asset outflows. We think share repurchases, like the $900M completed in 2025, will be a key component supporting the EPS growth target and should aid management's efforts to achieve guidance going forward.

$PFG

Lam Research Likely to Benefit from Healthy Wafer Fabrication Equipment Landscape, RBC Says

Related Articles

Newmont Posts Higher Q1 Adjusted Earnings, Sales

Research Alert: Pfg Q1 Eps Beat On Strong Retirement/benefits; Buybacks Key To 9%-12% Goal

ONEOK Keeps Quarterly Dividend at $1.07 a Share, Payable May 15 to Holders of Record May 4